Literature DB >> 6104205

Complement-fixing islet-cell antibodies in type I diabetes and in susceptible patients with autoimmune diseases.

C Betterle, A Caretto, A Tiengo, A Trevisan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104205     DOI: 10.1016/s0140-6736(80)92685-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives.

Authors:  C Betterle; F Zanette; B Pedini; F Presotto; L B Rapp; C M Monciotti; F Rigon
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

2.  Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M L Olsson; G Sundkvist; A Lernmark
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

3.  Immune abnormalities in diabetic patients not requiring insulin at diagnosis.

Authors:  U Di Mario; W J Irvine; D Q Borsey; J L Kyner; J Weston; C Galfo
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

4.  Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes.

Authors:  H Kolb; K Dannehl; D Grüneklee; J Zielasek; J Bertrams; A Hübinger; F A Gries
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

5.  Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions.

Authors:  C Betterle; A Caretto; M Zeviani; B Pedini; C Salviati
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

6.  Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.

Authors:  A Mustonen; M Knip; N P Huttunen; R Puukka; M L Käär; H K Akerblom
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.